DB
CORT icon

Danske Bank’s Corcept Therapeutics CORT Stock Holding History

Danske Bank’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,100
Closed -$38.3K – 1258
2025
Q4 		$38.3K Sell
1,100
-14,969
-93% -$1.18M ﹤0.01% 1067
2025
Q3 		$1.34M Sell
16,069
-5,792
-26% -$419K ﹤0.01% 630
2025
Q2 		$1.6M Sell
21,861
-10,599
-33% -$768K ﹤0.01% 634
2025
Q1 		$3.71M Buy
32,460
+426
+1% +$25.9K 0.01% 579
2024
Q4 		$1.61M Sell
32,034
-6,882
-18% -$361K ﹤0.01% 743
2024
Q3 		$1.8M Sell
38,916
-4,081
-9% -$145K 0.01% 676
2024
Q2 		$1.4M Sell
42,997
-124,714
-74% -$3.42M 0.01% 688
2024
Q1 		$4.22M Buy
+167,711
New +$3.96M 0.01% 592

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Danske Bank's CORT Position: Q1 2026 in Review

Danske Bank sold out of Corcept Therapeutics (CORT) in Q1 2026, closing a stake of 1,100 shares — an estimated $38.3K sold.

Danske Bank first reported a position in CORT in Q1 2024 and held it in 8 quarters. The position peaked at $4.22M in Q1 2024. 352 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

  • Danske Bank reported no remaining Corcept Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Danske Bank sold 1,100 Corcept Therapeutics shares in Q1 2026, an estimated $38.3K.
  • Danske Bank first reported a position in Corcept Therapeutics in Q1 2024 and held it in 8 quarters.
  • Danske Bank's Corcept Therapeutics position peaked at $4.22M in Q1 2024.
  • 352 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.